NEWS
​
New Formulation Equipment
​
May 2023
​
Exemplify is on its way to building best-in-class, cutting-edge new GMP drug product R&D facilities that will allow it to provide end-to-end services ranging from GMP and non-GMP drug product development to phase 1 and 2 clinical supplies of various oral, parenteral, and topical formulation dosage forms. Our facility will be ready by Jun 2023.
Welcome Dr. Jay Patel
​
January, 2023
​
Exemplify BioPharma welcomes Dr. Jay Patel, "Vice President of Formulation Development" in our newly created Pharmaceutical Sciences department. Dr. Patel has 10+ years of experience in formulation development and DP regulatory CMC. He will be leading the mission of building the formulation development capabilities at Exemplify! We are really excited to have Jay on the leadership team!
Symeres Acquires Exemplify
​
November, 2022
​
Symeres, a leading global drug discovery Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), today announces the acquisition of Exemplify BioPharma (or “Exemplify”), a US based CRO that provides integrated drug development services in Process & Analytical Chemistry and Formulation Development to pharmaceutical and biotech partners. Full Press Release
We have moved!
​
May, 2022
​
Exemplify has recently relocated to a new, state-of-the-art facility. Our new, >18,000 sq. ft. laboratory has expanded room for our growing analytical, process, and formulation departments and capabilities.
Scale-up Facilities
​
March, 2021​
​
We recently installed a new Buchi R-220 Rotary Evaporator in our kilo-lab. It is an exciting time in the Process Chemistry department as we expand our scale-up capabilities!
.png)
Welcome Dr. John Dillon
​
February 1, 2021
​
Exemplify BioPharma is proud to welcome Dr. John Dillon as a senior scientific advisor. As Exemplify BioPharma strives to meet growing demand and new clients’ needs, Dr. Dillon will help to re-affirm our commitment to establish new service areas. His experience in the field of early biologics development, biocatalysis, and biologics manufacturing will be integral to the expansion of Exemplify BioPharma’s business from its current support of small molecule CMC into the field of biologics CMC development.
ChemOutsourcing
​
September 19, 2019
​
Exemplify BioPharma would like to thank everyone who stopped by our booth at the recent ChemOutsourcing event and made it such a success!
